Generate Biomedicines
Signal active
Organization
Contact Information
Overview
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.
About
Industries
Biotechnology, Health Care, Medical, Product Research
Founded
2018
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Generate Biomedicines headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Product Research sector. The company focuses on Biotechnology and has secured $33.3B in funding across 48 round(s). With a team of 101-250 employees, Generate Biomedicines is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Generate Biomedicines, raised $273.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
12
Lead Investors
0
Total Funding Amount
$693.0M
Details
3
Generate Biomedicines has raised a total of $693.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 50.0M | ||
| 2021 | Early Stage Venture | 370.0M | ||
| 2023 | Late Stage Venture | 273.0M |
Investors
Generate Biomedicines is funded by 32 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Generate Biomedicines | - | FUNDING ROUND - Generate Biomedicines | 273.0M |
| Modi Ventures | - | FUNDING ROUND - Modi Ventures | 273.0M |
| David Beazley | - | FUNDING ROUND - David Beazley | 273.0M |
| Generate Biomedicines | - | FUNDING ROUND - Generate Biomedicines | 273.0M |
Recent Activity
There is no recent news or activity for this profile.